← Evidence map

ArticleAging2021

Discovery of a novel AR/HDAC6 dual inhibitor for prostate cancer treatment.

Maojun Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 33621955